YHB Investment Advisors, Inc.
Source: SEC Form 13F · as of Mar 2026YHB Investment Advisors, Inc. holds 20 biotech & pharma companies tracked by BioSniper, totaling $54.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$54.0M
| Company | Shares | Value |
|---|---|---|
| AMGNAMGEN INC | 45,836 | $16.1M |
| ABBVAbbVie Inc. | 36,951 | $8.0M |
| LLYELI LILLY & Co | 8,516 | $7.8M |
| JNJJOHNSON & JOHNSON | 24,259 | $5.9M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 17,409 | $4.7M |
| ZTSZoetis Inc. | 20,374 | $2.4M |
| ELVElevance Health Inc. | 5,297 | $1.6M |
| PFEPFIZER INC | 48,213 | $1.4M |
| MRKMerck & Co., Inc. | 8,448 | $1.0M |
| GILDGILEAD SCIENCES, INC. | 5,804 | $809K |
| BMYBRISTOL MYERS SQUIBB CO | 11,053 | $670K |
| NVSNovartis AG | 3,553 | $543K |
| ABTABBOTT LABORATORIES | 4,920 | $505K |
| GEHCGE HealthCare Technologies Inc. | 6,577 | $468K |
| REGNREGENERON PHARMACEUTICALS, INC. | 568 | $439K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 841 | $376K |
| IDXXIDEXX LABORATORIES INC /DE | 635 | $357K |
| PMPhilip Morris International Inc | 2,141 | $354K |
| MCKMcKesson Corporation | 389 | $337K |
| VTRSViatris Inc | 10,057 | $136K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.